 | |
| Clinical data | |
|---|---|
| Other names | Thymoxamine |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| DrugBank |
|
| ChemSpider | |
| UNII | |
| KEGG |
|
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.000.186 |
| Chemical and physical data | |
| Formula | C16H25NO3 |
| Molar mass | 279.380 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Moxisylyte, also known asthymoxamine, is a drug used inurology for the treatment oferectile dysfunction.[1] It is anα1-adrenergicantagonist.[2] In the United Kingdom, Moxisylyte is marketed as Opilon (Archimedes Pharma UK Ltd) and is used for the short-term treatment of primaryRaynaud's syndrome. This is a condition where the fingers and toes become discoloured and is triggered by responses to cold, or emotional distress. Opilon tablets help by improving blood circulation to the extremities.[3][4]
 | Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byexpanding it. |
 | Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |
